However, it is difficult to distinguish breast cancers from sclerosing adenosis with USE and α-SMA is also expressed in sclerosing adenosis, which might interfere with the consistency between USE scoring and myofibroblast distribution. The gene discussed is ACTA1; the disease is breast cancer.